GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kilitch Drugs (India) Ltd (BOM:524500) » Definitions » Cyclically Adjusted PB Ratio

Kilitch Drugs (India) (BOM:524500) Cyclically Adjusted PB Ratio : 3.31 (As of Jun. 04, 2025)


View and export this data going back to 2001. Start your Free Trial

What is Kilitch Drugs (India) Cyclically Adjusted PB Ratio?

As of today (2025-06-04), Kilitch Drugs (India)'s current share price is ₹430.40. Kilitch Drugs (India)'s Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was ₹129.87. Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio for today is 3.31.

The historical rank and industry rank for Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio or its related term are showing as below:

BOM:524500' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 2.32   Med: 2.57   Max: 3.55
Current: 3.33

During the past years, Kilitch Drugs (India)'s highest Cyclically Adjusted PB Ratio was 3.55. The lowest was 2.32. And the median was 2.57.

BOM:524500's Cyclically Adjusted PB Ratio is ranked worse than
70.71% of 693 companies
in the Drug Manufacturers industry
Industry Median: 1.94 vs BOM:524500: 3.33

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Kilitch Drugs (India)'s adjusted book value per share data for the three months ended in Mar. 2025 was ₹125.811. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is ₹129.87 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Kilitch Drugs (India) Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kilitch Drugs (India) Cyclically Adjusted PB Ratio Chart

Kilitch Drugs (India) Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 2.78

Kilitch Drugs (India) Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 2.67 - 2.78

Competitive Comparison of Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio falls into.


;
;

Kilitch Drugs (India) Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=430.40/129.87
=3.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kilitch Drugs (India)'s Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Kilitch Drugs (India)'s adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=125.811/157.5517*157.5517
=125.811

Current CPI (Mar. 2025) = 157.5517.

Kilitch Drugs (India) Quarterly Data

Book Value per Share CPI Adj_Book
201003 56.119 65.030 135.962
201103 63.713 70.768 141.845
201203 86.568 76.889 177.385
201206 0.000 79.567 0.000
201209 177.510 82.244 340.048
201212 0.000 83.774 0.000
201303 89.973 85.687 165.432
201403 90.862 91.425 156.582
201503 90.598 97.163 146.907
201603 81.428 102.518 125.140
201703 76.481 105.196 114.545
201803 81.581 109.786 117.075
201806 0.000 111.317 0.000
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 78.839 118.202 105.085
201906 0.000 120.880 0.000
201909 78.254 123.175 100.094
201912 0.000 126.235 0.000
202003 76.618 124.705 96.799
202006 0.000 127.000 0.000
202009 78.791 130.118 95.403
202012 0.000 130.889 0.000
202103 82.045 131.771 98.097
202106 0.000 134.084 0.000
202109 85.751 135.847 99.452
202112 0.000 138.161 0.000
202203 89.261 138.822 101.304
202206 0.000 142.347 0.000
202209 92.892 144.661 101.170
202212 0.000 145.763 0.000
202303 97.290 146.865 104.370
202306 0.000 150.280 0.000
202309 104.105 151.492 108.269
202312 0.000 152.924 0.000
202403 109.620 153.035 112.856
202406 0.000 155.789 0.000
202409 117.722 157.882 117.476
202412 0.000 158.323 0.000
202503 125.811 157.552 125.811

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Kilitch Drugs (India)  (BOM:524500) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Kilitch Drugs (India) Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Kilitch Drugs (India)'s Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Kilitch Drugs (India) Business Description

Traded in Other Exchanges
Address
Waman Tukaram Patil Marg, 37/39, Ujagar Industrial Estate, Deonar, Mumbai, MH, IND, 400 088
Kilitch Drugs (India) Ltd is an India-based pharmaceutical company. It is engaged in the manufacture and sales of pharmaceutical products. The company offers parenteral and nasal products, oral formulations, effervescent tablets, nutritional products, medical devices, and cosmetic and health products. Some of the products offered by the company are Roipar, Roivit, PH-7, C-Seal, SRO kit, 9-VIT, HPURE, and others. The company has one reportable segment, which is the development and operations of the Pharmaceutical business.

Kilitch Drugs (India) Headlines

No Headlines